Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

Share Price is delayed by 15 minutes
Get Live Data
4,678.00    42.00 (0.91%)
Bid:
4,676.00
Ask:
4,682.00
Spread: 6.00 (0.128%)
Market Cap: £1.44b
CKN Live PriceLast checked at - London Stock Exchange

Intraday Clarkson Share Chart

UPDATE RE ACQUISITION

28 Jan 2015 07:00

RNS Number : 3127D
Clarkson PLC
28 January 2015
Β 

ο»Ώ

This announcement and the information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from australia, canada, Japan, the republic of south africa, the united states or any other jurisdiction in which the same would be unlawful. please see the important notice at the end of this announcement.

Β 

CLARKSON PLC

Β 

Update re acquisition

Β 

28 January 2015

Β 

Further to the announcement by Clarkson PLC ("Clarksons") on 27 November 2014 of its proposed acquisition of RS Platou ASA and the further announcement on 23 December 2014 regarding the result of the General Meeting and shareholder approval of the Acquisition, Clarksons is today pleased to announce that it has now obtained certain regulatory approvals that were conditions to Completion of the Acquisition.

Β 

As a result, in accordance with paragraph 5.6.19G of the Listing Rules, applications have been made to the Financial Conduct Authority for re-admission of the Existing Ordinary Shares and the admission of the Consideration Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that, subject to the fulfilment of the remaining conditions, Completion of the Acquisition and Re-Admission will occur at 8.00 a.m. on 2 February 2015.

Β 

Under the terms of the Acquisition, the final number of Consideration Shares to be allotted and issued by Clarksons to the Sellers is 9,518,369 and following Re-Admission it is anticipated that the total number of ordinary shares that the Company has in issue will be 30,116,758.

Β 

Capitalised terms used in this announcement shall have the meanings as set out in the prospectus published by Clarksons on 17 December 2014.

Β 

For further information contact:

Β 

Clarkson PLC

+44 207 334 0000

Andi Case

Jeff Woyda

Nomura International plc

+44 207 102 1000

Andrew McNaught

Andrew Forrester

Nicholas Marren

Panmure Gordon (UK) Limited

Richard Gray

Andrew Potts

Tom Salvesen

+44 207 886 2500

Hudson Sandler

+44 207 796 4133

Andrew Nicolls

Β 

IMPORTANT NOTICE

This Announcement and the information contained in it is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia, collectively the "United States") Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction in which the same would be restricted, unlawful or unauthorised (each a "Restricted Territory"). This Announcement is for information purposes only and does not constitute an offer to sell or issue or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in any Restricted Territory or to any person to whom it is unlawful to make such offer or solicitation. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions. Subject to certain exemptions, the securities referred to herein may not be offered or sold in any Restricted Territory or for the account or benefit of any national resident or citizen of any Restricted Territory.

This Announcement and the information contained herein is not an offer of securities for sale in the United States and there will be no public offer of securities in the United States. The securities discussed herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws or with any securities regulatory authority of any other state or other jurisdiction of the United States, and may not be offered, sold or transferred, directly or indirectly, in the United States absent registration under the Securities Act or an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any other state or jurisdiction of the United States.

This Announcement has been issued by, and is the sole responsibility of the Company. No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Nomura International plc ("Nomura") or Panmure Gordon (UK) Limited ("Panmure Gordon") or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Nomura, which is authorised by the Prudential Regulation Authority and is regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company in relation to the Acquisition and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the Acquisition or any other matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Nomura by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Nomura nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Nomura or any of its respective affiliates in connection with the Company or the Acquisition. Nomura and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Nomura or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future.

Panmure Gordon, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to any matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Panmure Gordon by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Panmure Gordon nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Panmure Gordon or any of its respective affiliates in connection with the Company. Panmure Gordon and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Panmure Gordon or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as a promise or representation in this respect, whether as to the past or the future.

This Announcement does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe, for, underwrite or otherwise acquire, any securities of the Company or any member of its group in any jurisdiction or an inducement to enter into investment activity.

The information in this Announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

The information contained in this Announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein. You should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQSEAFAWFISEDF
Date   Source Headline
10th May 201312:00 pmRNSAGM and Interim Management Statement
8th May 20135:39 pmRNSHolding(s) in Company
3rd May 20134:16 pmRNSDirector/PDMR Shareholding
2nd May 201312:58 pmRNSHolding(s) in Company
26th Apr 201311:07 amRNSNotification of major interest in shares
26th Apr 201311:04 amRNSNotification of major interest in shares
3rd Apr 20133:38 pmRNSAnnual Financial Report
2nd Apr 20134:32 pmRNSDirector/PDMR Shareholding
25th Mar 20137:00 amRNSChairman retirement and appointment of successor
11th Mar 20134:56 pmRNSCompany Secretary Change
7th Mar 20137:00 amRNSPreliminary Results
31st Jan 20133:46 pmRNSDirector Declaration
4th Jan 20137:00 amRNSPre-Close Trading Update
7th Nov 20127:00 amRNSInterim Management Statement
25th Oct 20123:45 pmRNSHolding(s) in Company
6th Sep 20129:47 amRNSHalf Yearly Report
22nd Aug 20127:00 amRNSInterim Results
17th Aug 20123:38 pmRNSHolding(s) in Company
14th Aug 20123:36 pmRNSHolding(s) in Company
29th Jun 20127:00 amRNSPre-Close Trading Update
12th Jun 201210:39 amRNSHolding(s) in Company
1st Jun 20123:41 pmRNSDirector/PDMR Shareholding
11th May 20124:19 pmRNSDirector/PDMR Shareholding
11th May 20124:04 pmRNSResult of AGM
11th May 201212:00 pmRNSAGM and Interim Management Statement
19th Apr 20124:46 pmRNSAnnual Information Update
4th Apr 20124:18 pmRNSAnnual Financial Report
8th Mar 201212:34 pmRNSLegal Settlement
8th Mar 20127:01 amRNSBoard Change
8th Mar 20127:00 amRNSFinal Results
27th Feb 20123:49 pmRNSHolding(s) in Company
24th Feb 20123:47 pmRNSHolding(s) in Company
13th Feb 20122:47 pmRNSHolding(s) in Company
10th Feb 20124:14 pmRNSHolding(s) in Company
10th Feb 20122:47 pmRNSHolding(s) in Company
10th Feb 20129:42 amRNSBoard Change
1st Feb 20124:36 pmRNSHolding(s) in Company
23rd Jan 20129:24 amRNSSettlement of Legal Costs
13th Jan 201210:14 amRNSHolding(s) in Company
4th Jan 20121:18 pmRNSPre Close Trading Update
1st Dec 201112:42 pmRNSAcquisition of Boxton Holding & Bridge Maritime
1st Dec 20117:00 amRNSAcquisition of EnShip Ltd
8th Nov 20117:00 amRNSInterim Management Statement
4th Nov 201112:39 pmRNSSettlement of Legal Costs
18th Oct 20114:03 pmRNSDirector/PDMR Shareholding
22nd Sep 201112:56 pmRNSDoc re. Interim Report 2011
31st Aug 20114:20 pmRNSDirector/PDMR Shareholding
24th Aug 20113:11 pmRNSDirector/PDMR Shareholding
24th Aug 20117:00 amRNSInterim Results
30th Jun 20117:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.